Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study.

Danese, Silvio; Colombel, Jean-Frederic; Lukas, Milan; Gisbert, Javier P; D'Haens, Geert; Hayee, Bu'hussain; Panaccione, Remo; Kim, Hyun-Soo; Reinisch, Walter; Tyrrell, Helen; Oh, Young S; Tole, Swati; Chai, Akiko; Chamberlain-James, Kirsten; Tang, Meina Tao; Schreiber, Stefan

Danese, Silvio; Colombel, Jean-Frederic; Lukas, Milan; Gisbert, Javier P; D'Haens, Geert; Hayee, Bu'hussain; Panaccione, Remo; Kim, Hyun-Soo; Reinisch, Walter; Tyrrell, Helen; Oh, Young S; Tole, Swati; Chai, Akiko; Chamberlain-James, Kirsten; Tang, Meina Tao; Schreiber, Stefan.

Affiliation

Danese S; Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy.
Colombel JF; Icahn School of Medicine, Mount Sinai, New York City, NY, USA.
Lukas M; Clinical and Research Centre for Inflammatory Bowel Diseases, ISCARE IVF Clinical Center Ceskomoravská, Prague, Czech Republic.
Gisbert JP; Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa, Universidad Autónoma de Madrid and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain.
D'Haens G; Department of Gastroenterology, Imelda Hospital, Amsterdam University Medical Center, Amsterdam, Netherlands.
Hayee B; King's College Hospital Denmark Hill London, London, UK.
Panaccione R; University of Calgary, Calgary, AB, Canada.
Kim HS; Department of Internal Medicine 20, Yonsei University, Wonju, South Korea.
Reinisch W; Medical University of Vienna, Vienna, Austria.
Tyrrell H; Roche, Welwyn Garden City, UK.
Oh YS; Genentech, South San Francisco, CA, USA.
Tole S; Genentech, South San Francisco, CA, USA.
Chai A; Genentech, South San Francisco, CA, USA.
Chamberlain-James K; Roche, Welwyn Garden City, UK.
Tang MT; Genentech, South San Francisco, CA, USA.
Schreiber S; Christian-Albrechts University, Kiel, Germany. Electronic address: s.schreiber@mucosa.de.

Lancet Gastroenterol Hepatol ; 7(2): 118-127, 2022 02.

Article de En | MEDLINE | ID: mdl-34798038

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Agents gastro-intestinaux / Rectocolite hémorragique / Anticorps monoclonaux humanisés / Infliximab Type d'étude: Clinical_trials Limites: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Lancet Gastroenterol Hepatol Année: 2022 Type de document: Article Pays d'affiliation: Italie Pays de publication: Pays-Bas

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google